CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention

From U.S. Centers for Disease Control and Prevention

June 2005

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Research Rationale

Trial Designs and Objectives

Safeguards and Services for Trial Participants

Community Involvement
- What is being done to solicit input from the communities in which these trials will be conducted?

Anticipated Results and Impact
Next

This article was provided by U.S. Centers for Disease Control and Prevention. Visit the CDC's website to find out more about their activities, publications and services.

Two New Studies Support Use of PrEP for HIV Prevention Among Heterosexual Men and Women

CDC Statement: CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection Among Heterosexuals

U. Washington Statement: Pivotal Study Finds That HIV Medications Are Highly Effective as Prophylaxis Against HIV Infection in Men and Women in Africa

iPrEx Statement: Two Major Studies Prove HIV Pre-Exposure Prophylaxis (PrEP) Works in in Heterosexual Women and Men; Build on iPrEx Data Showing PrEP Reduces HIV Infections in Men Who Have Sex With Men

More on HIV Medications for HIV Prevention

Two New Studies Support Use of PrEP for HIV Prevention Among Heterosexual Men and Women

CDC Statement: CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection Among Heterosexuals

U. Washington Statement: Pivotal Study Finds That HIV Medications Are Highly Effective as Prophylaxis Against HIV Infection in Men and Women in Africa

More on HIV Medications for HIV Prevention

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

Donna Summer, Coming Out, and How AIDS Changed It All: A Blog Entry by Mark S. King

Buffalo Bills Player Tweets HIV Test Results: Over-Share or Encouraging? A Blog Entry by Kellee Terrell

Study Finds HIV Infection Is an Independent Risk Factor for Lung Cancer

Broad-Spectrum Antivirals: The Future of HIV Treatment?

How Did I Get Here?

More >>

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.

CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention

Table of Contents